Information  X 
Enter a valid email address

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

By BFN News | 10:50 AM | Friday 07 February, 2020

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1550p (from 1650p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t